Shenzhen Daily: Projects worth ¥60b inked at Guangming investment conference July 8, 2022 7:32 am|SHENZHEN, China, July 8, 2022 /PRNewswire/ — A news report by Shenzhen Daily:
Innovid Announces Changes to its Board of Directors July 8, 2022 7:30 am|NEW YORK, July 8, 2022 /PRNewswire/ — Innovid Corp. (NYSE: CTV) (the “Company”), an independent advertising platform for…
“Captain Tsubasa: Dream Team” Debuts New Players Including Taro Misaki Wearing the 2022 Season J.LEAGUE Official Kits July 8, 2022 7:30 am|TOKYO, July 8, 2022 /PRNewswire/ — KLab Inc., a leader in online mobile games, announced that its head-to-head football…
AWH Announces Share Purchase Made by Every Independent Director on the Board of Directors July 8, 2022 7:30 am|– Emily Paxhia, Scott Swid, and Joseph Hinrichs purchase approximately 60,352 Class A Common Shares in aggregate –
1 runner killed in crash at race in North Carolina July 8, 2022 7:22 am|LINVILLE, N.C. (WBTV/Gray News) – Multiple people were injured and one killed after an accident involving a vehicle…
Buyer Consortium Led by Recco Control Technology and Dazheng Group Announces Engagement of UBS as Financial Advisor and Reaffirms Non-Binding Indicative Offer of $25 Per Share to Acquire Hollysys July 8, 2022 7:15 am|SINGAPORE and HONG KONG, July 8, 2022 /PRNewswire/ — Buyer consortium led by Recco Control Technology Pte. Ltd. (“Recco…
Daqo New Energy's Subsidiary Xinjiang Daqo Provides Preliminary Estimates of Net Profit for the first half of 2022 July 8, 2022 7:12 am|SHANGHAI, July 8, 2022 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy”, the “Company” or…
Rational Vaccines Herpes Simplex Type 2 (HSV-2) Therapeutic Vaccine Candidate Demonstrates Efficacy in a Therapeutic Animal Study July 8, 2022 7:00 am|NIH-funded study shows RVX201 exhibits robust protection against recurrent HSV-2 disease in guinea pig model
CASI PHARMACEUTICALS ANNOUNCES ITS PARTNER, PRECISION AUTOIMMUNE THERAPEUTICS CO., LTD HAS COMPLETED FIRST-ROUND FINANCING OF $21 MILLION July 8, 2022 7:00 am|~ Precision Autoimmune Therapeutics (PAT) Announced the completion of first-round financing of the equivalent of approximately US $21…